기준가
$12.78
운용 규모
$2.4M
보수율
-
배당수익률
0.00%
베타
-1.18
통화
USD
| YTD | 1개월 | 3개월 | 1년 | 3년 | 5년 |
|---|---|---|---|---|---|
| -32.54% | -26.37% | -27.82% | -61.80% | -30.36% | -17.01% |
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
설정일: 2010-04-06